Literature DB >> 12727339

Optimization of vesicular stomatitis virus-G pseudotyped feline immunodeficiency virus vector for minimized cytotoxicity with efficient gene transfer.

Jae Jin Song1, Boyoung Lee, Jin Woo Chang, Joo-Hang Kim, Yunhee Kim Kwon, Heuiran Lee.   

Abstract

FIV-based lentiviral vector has shown a unique opportunity as an efficient gene delivery vehicle, especially to nondividing human cells. Here, we genetically reconstructed the FIV-based vector by serially deleting residual virus genes of gag and vif, leading to minimized cytotoxicity together with efficient virus production and gene transfer. The modified FIV- based vector was generated by transiently transfecting 293T cells with three plasmids of the gene transfer vector with minimal gag region, the packaging plasmid without vif and the VSV-G-expressing plasmid. The vector was routinely generated as many as 1 x 10(7) transducing particles per ml and easily concentrated by simple centrifugation. The cytotoxic effect significantly decreased in sensitive cells to FIV infection even at high multiplicity of infection (MOI), such as 500. Moreover, the transduction efficiency was consistently retained after cell cycle was arrested in a variety of human cells. Taken together, our results suggest that the modified VSV-G pseudotyped FIV-based vector efficiently transduce dividing and nondividing human cells with minimal cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727339     DOI: 10.1016/s0168-1702(03)00047-9

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  4 in total

Review 1.  Human gene therapy vectors derived from feline lentiviruses.

Authors:  Román A Barraza; Eric M Poeschla
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

2.  Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells).

Authors:  Joanna L Howarth; Youn Bok Lee; James B Uney
Journal:  Cell Biol Toxicol       Date:  2009-10-15       Impact factor: 6.691

Review 3.  Non-Primate Lentiviral Vectors and Their Applications in Gene Therapy for Ocular Disorders.

Authors:  Vincenzo Cavalieri; Elena Baiamonte; Melania Lo Iacono
Journal:  Viruses       Date:  2018-06-09       Impact factor: 5.048

Review 4.  Gene Therapy Applications of Non-Human Lentiviral Vectors.

Authors:  Altar M Munis
Journal:  Viruses       Date:  2020-09-29       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.